Intravenous lidocaine: Effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma - A report of a series

Anesthesia and Analgesia

Volumn 85, Issue 4, 1997, Pages 794-796

  Wallace, Mark S ^a   Lee, Judy ^a   Sorkin, Linda ^a   Dunn, Joseph S ^a   Yaksh, Tony ^a   Yu, Alice ^b  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIDOCAINE; MORPHINE;

ANALGESIA; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; NEUROBLASTOMA; PAIN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; FEMALE; GANGLIOSIDES; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; MALE; NEUROBLASTOMA; PAIN;

EID: 0030783145     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199710000-00014     Document Type: Article

References (16)

1. Cheung NKV, Lazarus H, Miraldi FD, et al. Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 1987;5:1430-40.
2. Handgretinger R, Baader P, Dopfer R, et al. A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14G2a. Cancer Immunol Immunother 1992;35:199-204.
3. Saleh MN, Khazaeli MB, Wheeler RH, et al. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res 1992;52:4342-7.
4. Svennerholm L, Bostrom K, Fredman P, et al. Gangliosides and allied glycosphyngolipids in human peripheral nerve and spinal cord. Biochem Biophys Acta 1994;1214:115-23.
5. Beyer JE, Wells N. The assessment of pain in children. Pediatr Clin North Am 1989;36:837-51.
6. Huang CS, Uttenreuther M, Reisfeld RA, Yu AL. Immunotherapy of GD2 (+) tumors with a murine monoclonal antibody (MAB) 14G2a: a phase I study. Proc ASCO 1992;11:21.
7. Yu AL, Gilles SD, Reisfeld RA. Phase I clinical trial of ch1418 in patients with refractory neuroblastoma. Proc ASCO 1991; 10:318.
8. Kracun I, Rosner H, Cosovic C. Topographical distribution of the gangliosides in the developing and adult human brain. In: Tettamanti G, Ledeen RW, Sandkoff K, et al., eds. Gangliosides and neuronal plasticity: Fidia research series. Padova: Liviani, 1986:67-76.
9. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996;66:69-77.
10. Bach FW, Jensen TS, Kastrup J, et al. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990;40:29-34.
11. Kastrup J, Petersen P, Dejgard A, et al. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy? Pain 1987;28:69-75.
12. Lee E, Donovan K. Reactivation of phantom limb pain after combined interscalene brachial plexus block and general anesthesia: successful treatment with intravenous lidocaine. Anesthesiology 1995;82:295-8.
13. Marchettini P, Lacerenza M, Marangoni C, et al. Lidocaine test in neuralgia. Pain 1992;48:377-82.
14. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-8.
15. Boas RA, Covino BG, Shahnarian A. Analgesic responses to I. V. lignocaine. Br J Anaesth 1982;54:501-5.
16. Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991 74: 949-51.